Global disparities and future directions in cardio-oncology training: an international survey of cardiology trainees from the international cardio-oncology society

Cardio-oncology has emerged as a vital subspecialty as the population of cancer patients with cardiovascular comorbidities and treatment-related cardiotoxicities grows. Despite its clinical importance, concerns have been raised as to the integration of cardio-oncology into cardiology training. To understand the global landscape of cardio-oncology training, the International Cardio-Oncology Society (IC-OS) carried out a survey of cardio-oncology education. An electronic survey of international cardiology trainees was conducted between March and July 2024. The survey assessed the extent of cardio-oncology teaching, clinical exposure, awareness of cardio-oncology guidelines and professional societies, and interest in future fellowship, research and career in cardio-oncology. 131 cardiology trainees from across the globe responded to the survey, (51% early years trainees, 49% late years trainees). 65% of respondents had cardio-oncology services at their current place of work. Only 39% of respondents reported receiving specific training in cardio-oncology, with significantly global disparity (UK, USA and Canada trainees = 64%, rest of the world 37%, p < 0.001). Clinical exposure was limited, with only 20% of trainees reporting having carried out inpatient cardio-oncology consultations and 17% reporting no cardio-oncology experience. Awareness of the cardio-oncology guidelines was good (75%), with awareness associated confidence in practicing cardio-oncology, as were receiving cardio-oncology training and > 50 h of clinical cardio-oncology experience. This study highlights the urgent need for global standardization of cardio-oncology training, expanded fellowship programs, and increased awareness of guidelines and societies. Addressing these gaps is essential to ensure equitable, high-quality cardiovascular care for cancer patients worldwide.

Authors

Institutions

Publication Details

Journal
Cardio-Oncology
Published
2026-01-07
DOI
https://doi.org/10.1186/s40959-025-00419-1
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global disparities and future directions in cardio-oncology training: an international survey of cardiology trainees from the international cardio-oncology society

Arjun Ghosh, Daniel J. Lenihan, James M. Wilson, S. Dent et al.
Cardio-Oncology
Chemotherapy-induced cardiotoxicity and mitigation
article

Global disparities and future directions in cardio-oncology training: an international survey of cardiology trainees from the international cardio-oncology society

Arjun Ghosh, Daniel J. Lenihan, James M. Wilson, S. Dent, Carolina Carvalho Silva, Rhys Gray, J Lushington, Daniel Sierra-Lara Martinez, José Álvarez, Sebastian Szmit, Stephen Caselli, Cristian Herrera Flores
article en

Abstract

Cardio-oncology has emerged as a vital subspecialty as the population of cancer patients with cardiovascular comorbidities and treatment-related cardiotoxicities grows. Despite its clinical importance, concerns have been raised as to the integration of cardio-oncology into cardiology training. To understand the global landscape of cardio-oncology training, the International Cardio-Oncology Society (IC-OS) carried out a survey of cardio-oncology education. An electronic survey of international cardiology trainees was conducted between March and July 2024. The survey assessed the extent of cardio-oncology teaching, clinical exposure, awareness of cardio-oncology guidelines and professional societies, and interest in future fellowship, research and career in cardio-oncology. 131 cardiology trainees from across the globe responded to the survey, (51% early years trainees, 49% late years trainees). 65% of respondents had cardio-oncology services at their current place of work. Only 39% of respondents reported receiving specific training in cardio-oncology, with significantly global disparity (UK, USA and Canada trainees = 64%, rest of the world 37%, p < 0.001). Clinical exposure was limited, with only 20% of trainees reporting having carried out inpatient cardio-oncology consultations and 17% reporting no cardio-oncology experience. Awareness of the cardio-oncology guidelines was good (75%), with awareness associated confidence in practicing cardio-oncology, as were receiving cardio-oncology training and > 50 h of clinical cardio-oncology experience. This study highlights the urgent need for global standardization of cardio-oncology training, expanded fellowship programs, and increased awareness of guidelines and societies. Addressing these gaps is essential to ensure equitable, high-quality cardiovascular care for cancer patients worldwide.

Cardio-OncologyVol. 12(1)
University College Hospital (GB), St Bartholomew's Hospital (GB), Queen Mary University of London (GB), City University of New York (US), Tecnológico Nacional de México (MX), D’Or Institute for Research and Education (BR), Saint Francis Medical Center (US), National Institute of Oncology (HU), Instituto de Investigación Biomédica de Salamanca (ES), Postgraduate School of Molecular Medicine (PL), Vietnam National Children's Hospital (VN), William Harvey Research Institute (GB), University College London (GB), University of Rochester (US), New York University (US)
Partnerships for the goals
Openalex Percentile: Top 95%
Chemotherapy-induced cardiotoxicity and mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.